Status:
COMPLETED
Incorporating Financial Incentives to Increase Smoking Cessation Among Asian Americans Residing in New York City
Lead Sponsor:
NYU Langone Health
Conditions:
Smoking Cessation
Smoking, Cigarette
Eligibility:
All Genders
18-90 years
Phase:
NA
Brief Summary
Financial incentives for motivating health change have been increasingly employed in various healthcare sectors. They can be a potentially effective approach to promote smoking behavioral change and i...
Eligibility Criteria
Inclusion
- Asian American
- current smoker who smokes at least 10 cigarettes daily (verified by a CO level of 8 ppm or above)
- New York City resident
- able to complete three month follow-up assessments in person, can provide a telephone number
- declining the use of Chantix for smoking cessation.
Exclusion
- \<18 years old
- pregnant
- cannot provide a telephone number, non-smokers or smokers that smoke fewer than 10 cigarettes daily, users of e-cigarettes or other tobacco products who are not interested in quitting smoking, marijuana users
- not a New York City resident
- unable to complete three month follow-up assessment in person
- unable to provide written consent
- agree to use Chantix for smoking cessation.
Key Trial Info
Start Date :
September 5 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2019
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT03397511
Start Date
September 5 2018
End Date
October 1 2019
Last Update
November 8 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
New York University School of Medicine
New York, New York, United States, 10016